BIOMAT Database Logo BIOMAT Database Logo

[RI cisternography with 111-In-DTPA]. 1976

Y Tokuriki, and Y Miwa, and T Murata, and T Fukumitsu, and T Matsumura

In contrast to 169Yb-DTPA the usage of 111In-DTPA, a new radiopharmaceutical, is not as yet popular for RI cisternography. This report deals with a comparative study of these two radiopharmaceuticals for RI cisternography. For the past one year 301 RI cisternography. For the past one year 301 RI cisternographies were performed in 160 cases at the Neurosurgical Survice of Shizuoka Rosai Hospital. Among those 169Yb-DTPA was used in 137 occasions, 111In-DTPA in 53, and both 169Yb-DTPA and 111In-DTPA in 30. The results of this study were as follow. 1. 111In-DTPA was chemically stable in intrathecal administration. 2. A reactive fever was minimal with 111In-DTPA if any. 3. There was no adverse reaction, such as aseptic meningitis, following 111In-DTPA cisternographies. 4. The effective half-life of 111In-DTPA was 16 hours, and that of 169Yb-DTPA 22 hours in this series. This means the men were exposed to radioactivity less with 111In-DTPA than with 169Yb-DTPA. 5. However, there was no difference in diagnostic value between these two radiopharmaceuticals, even 48 hours after intrathecal administration. From this study 111In-DTPA appears to be more suitable for RI cisternography than 169Yb-DTPA.

UI MeSH Term Description Entries
D007204 Indium A metallic element, atomic number 49, atomic weight 114.818, symbol In. It is named from its blue line in the spectrum.
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011868 Radioisotopes Isotopes that exhibit radioactivity and undergo radioactive decay. (From Grant & Hackh's Chemical Dictionary, 5th ed & McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed) Daughter Isotope,Daughter Nuclide,Radioactive Isotope,Radioactive Isotopes,Radiogenic Isotope,Radioisotope,Radionuclide,Radionuclides,Daughter Nuclides,Daugter Isotopes,Radiogenic Isotopes,Isotope, Daughter,Isotope, Radioactive,Isotope, Radiogenic,Isotopes, Daugter,Isotopes, Radioactive,Isotopes, Radiogenic,Nuclide, Daughter,Nuclides, Daughter
D011877 Radionuclide Imaging The production of an image obtained by cameras that detect the radioactive emissions of an injected radionuclide as it has distributed differentially throughout tissues in the body. The image obtained from a moving detector is called a scan, while the image obtained from a stationary camera device is called a scintiphotograph. Gamma Camera Imaging,Radioisotope Scanning,Scanning, Radioisotope,Scintigraphy,Scintiphotography,Imaging, Gamma Camera,Imaging, Radionuclide
D001927 Brain Diseases Pathologic conditions affecting the BRAIN, which is composed of the intracranial components of the CENTRAL NERVOUS SYSTEM. This includes (but is not limited to) the CEREBRAL CORTEX; intracranial white matter; BASAL GANGLIA; THALAMUS; HYPOTHALAMUS; BRAIN STEM; and CEREBELLUM. Intracranial Central Nervous System Disorders,Brain Disorders,CNS Disorders, Intracranial,Central Nervous System Disorders, Intracranial,Central Nervous System Intracranial Disorders,Encephalon Diseases,Encephalopathy,Intracranial CNS Disorders,Brain Disease,Brain Disorder,CNS Disorder, Intracranial,Encephalon Disease,Encephalopathies,Intracranial CNS Disorder
D001932 Brain Neoplasms Neoplasms of the intracranial components of the central nervous system, including the cerebral hemispheres, basal ganglia, hypothalamus, thalamus, brain stem, and cerebellum. Brain neoplasms are subdivided into primary (originating from brain tissue) and secondary (i.e., metastatic) forms. Primary neoplasms are subdivided into benign and malignant forms. In general, brain tumors may also be classified by age of onset, histologic type, or presenting location in the brain. Brain Cancer,Brain Metastases,Brain Tumors,Cancer of Brain,Malignant Primary Brain Tumors,Neoplasms, Intracranial,Benign Neoplasms, Brain,Brain Neoplasm, Primary,Brain Neoplasms, Benign,Brain Neoplasms, Malignant,Brain Neoplasms, Malignant, Primary,Brain Neoplasms, Primary Malignant,Brain Tumor, Primary,Brain Tumor, Recurrent,Cancer of the Brain,Intracranial Neoplasms,Malignant Neoplasms, Brain,Malignant Primary Brain Neoplasms,Neoplasms, Brain,Neoplasms, Brain, Benign,Neoplasms, Brain, Malignant,Neoplasms, Brain, Primary,Primary Brain Neoplasms,Primary Malignant Brain Neoplasms,Primary Malignant Brain Tumors,Benign Brain Neoplasm,Benign Brain Neoplasms,Benign Neoplasm, Brain,Brain Benign Neoplasm,Brain Benign Neoplasms,Brain Cancers,Brain Malignant Neoplasm,Brain Malignant Neoplasms,Brain Metastase,Brain Neoplasm,Brain Neoplasm, Benign,Brain Neoplasm, Malignant,Brain Neoplasms, Primary,Brain Tumor,Brain Tumors, Recurrent,Cancer, Brain,Intracranial Neoplasm,Malignant Brain Neoplasm,Malignant Brain Neoplasms,Malignant Neoplasm, Brain,Neoplasm, Brain,Neoplasm, Intracranial,Primary Brain Neoplasm,Primary Brain Tumor,Primary Brain Tumors,Recurrent Brain Tumor,Recurrent Brain Tumors,Tumor, Brain
D002542 Intracranial Embolism and Thrombosis Embolism or thrombosis involving blood vessels which supply intracranial structures. Emboli may originate from extracranial or intracranial sources. Thrombosis may occur in arterial or venous structures. Brain Embolism and Thrombosis,Cerebral Embolism and Thrombosis,Embolism and Thrombosis, Brain
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D002946 Cisterna Magna One of three principal openings in the SUBARACHNOID SPACE. They are also known as cerebellomedullary cistern, and collectively as cisterns. Magna, Cisterna

Related Publications

Y Tokuriki, and Y Miwa, and T Murata, and T Fukumitsu, and T Matsumura
[Clinical experience of RI cisternography with 111In-DTPA. (author's transl)].
April 1977, Radioisotopes,
Y Tokuriki, and Y Miwa, and T Murata, and T Fukumitsu, and T Matsumura
[Post-meningitis subdural hygroma in a child showing abnormal RI accumulation in 169Yb-DTPA RI cisternography].
August 1976, Kaku igaku. The Japanese journal of nuclear medicine,
Y Tokuriki, and Y Miwa, and T Murata, and T Fukumitsu, and T Matsumura
In-111 DTPA ommaya cisternography with delayed radiotracer activity demonstrated in the peritoneal cavity.
December 2009, Clinical nuclear medicine,
Y Tokuriki, and Y Miwa, and T Murata, and T Fukumitsu, and T Matsumura
Diagnosis of communicating intracranial arachnoidal cysts by 111-In-Ca-DTPA cisternography.
January 1986, Acta neurologica Belgica,
Y Tokuriki, and Y Miwa, and T Murata, and T Fukumitsu, and T Matsumura
Spontaneous intracranial hypotension: characteristic findings of radionuclide cisternography using In-111 DTPA
October 1999, Clinical nuclear medicine,
Y Tokuriki, and Y Miwa, and T Murata, and T Fukumitsu, and T Matsumura
Cisternography with 169 Yb-DTPA.
October 1971, Journal of nuclear medicine : official publication, Society of Nuclear Medicine,
Y Tokuriki, and Y Miwa, and T Murata, and T Fukumitsu, and T Matsumura
[RI-cisternography (author's transl)].
January 1976, No shinkei geka. Neurological surgery,
Y Tokuriki, and Y Miwa, and T Murata, and T Fukumitsu, and T Matsumura
[111In-DTPA cisternography].
February 1978, Kaku igaku. The Japanese journal of nuclear medicine,
Y Tokuriki, and Y Miwa, and T Murata, and T Fukumitsu, and T Matsumura
Cerebrospinal fluid fistula to the maxillary bone demonstrated by In-111 DTPA cisternography.
January 1997, Clinical nuclear medicine,
Y Tokuriki, and Y Miwa, and T Murata, and T Fukumitsu, and T Matsumura
Isotope cisternography with indium-111 DTPA in a patient with nearly no intellectual deficits and extensive hydrocephalus.
May 1990, Clinical nuclear medicine,
Copied contents to your clipboard!